Clinical Insights & Research

Sleep Pharmaceuticals Narcolepsy

Promising Data for First New Narcolepsy Drug in Ten Years, Pending Approval

Platform presentation highlights open-label, long-term safety and tolerability results, durability of effect over time in both EDS and cataplexy in patients with narcolepsy Harmony Biosciences, LLC (Harmony) recently presented new data on pitolisant at the 7th International Symposium on Narcolepsy in Beverly, MA. Pitolisant is an investigational product that has […]

lonhala magnair
Sleep Pharmaceuticals

Sunovion First To Offer Nebulized Long-Acting Muscarinic Antagonist (LAMA) For COPD In The U.S.

Sunovion Pharmaceuticals Inc. (Sunovion) today announced that Lonhala™ Magnair™ (glycopyrrolate) Inhalation Solution (25 mcg twice daily) is now available at pharmacies in the U.S. for the long-term, maintenance treatment of airflow obstruction in people with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. LONHALA MAGNAIR is the first […]

Dental Sleep Medicine

Intraoral Scanner Can Now Be Used to Produce Panthera Oral Appliances

Panthera Sleep designs, develops, manufactures and markets high-end Mandibular Advancement Devices (MAD) for the treatment of snoring and/or obstructive sleep apnea. The Planmeca Emerald™ intraoral scanner can now be smoothly integrated into sleep practices’ workflows. After scanning the upper and lower arches, first alone and then in occlusion, dentists can instantly export […]

sunovion LM_NebulizerSystem
Sleep Pharmaceuticals Product & Vendor Updates

Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD

Sunovion Pharmaceuticals Inc. today announced that the FDA approved the New Drug Application (NDA) for Lonhala™ Magnair™ (glycopyrrolate) Inhalation Solution (25 mcg twice daily), also known as SUN-101/eFlow®, for the long-term, maintenance treatment of airflow obstruction in people with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Sunovion […]